Several U-M Depression Center members collaborate on research initiatives that are part of the Pritzker Neuropsychiatric Disorders Research Consortium, a collaborative research enterprise comprised of several leading academic institutions and based on a long-term relationship between the Pritzker family and scientists at the various member institutions. The goal of the Consortium is to discover the neurobiological and genetic causes of severe psychiatric disorders (including major depression, bipolar disorder, and schizophrenia) and identify novel targets for their treatment. The other member institutions are University of California-Davis (UCD), University of California-Irvine (UCI), Stanford University, Cornell and HudsonAlpha.
The consortium maintains a "brain bank," a collection of high-quality post-mortem brain tissue taken from patients and individually matched controls post-mortem tissue, which provides member researchers with RNA samples for microarray analysis. Consortium researchers also engage in microarray studies to learn more about patterns of gene expression that differ between normal and diseased brains, studies of gene anatomy and ontology, efforts in novel genetics and genomics technologies, clinical research, and informatics. Learn more about the Consortium's work here.